Close
CDMO Safety Testing 2026
Novotech

Tower Cold Chain wins Queen’s Award for International Trade

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Novartis Expands Radioligand Therapy Manufacturing in US

Swiss pharmaceutical company Novartis has started construction of a...

Angelini Pharma Expands US Presence with Catalyst Pharmaceuticals Acquisition

Angelini Pharma has finalized a definitive agreement to acquire...

Are Glutathione Injections in NYC Worth It? A Complete Guide

When whatever you do to your skin makes it...
- Advertisement -

Pharmaceutical temperature-controlled specialist Tower Cold Chain has been honoured with a Queenโ€™s Award for Enterprise, the UKโ€™s highest accolade for business success. The company won its award for International Trade for Outstanding Short Term Growth in export sales made over the last three years.

Tower has been recognised for its robust, reliable, reusable thermal containers, that transport temperature sensitive pharmaceutical, life-science and biotech products. In the last 18 months overseas sales and the proportion of total sales exporting have increased significantly.

The company has seen particular success in the United States, Germany, Belgium, South Africa and China, coinciding with its on-going expansion of its global hub networks to maximise proximity and availability to Tower customers in all regions.

โ€œWe are tremendously proud to receive the Queenโ€™s Award for Enterprise: International Trade, which is a tribute to the expertise and hard work of the entire Tower team,โ€ commented Tower Cold Chainโ€™s CEO Niall Balfour. โ€œRecognising our international growth shows how we are focused on meeting our customersโ€™ global supply chain needs and will continue to invest and collaborate to deliver this.โ€

Tower has recently played a key role in ensuring the critical delivery of Covid-19 vaccines throughout the pandemic. In addition, the launch of both the KTM42D for ultra-cold temperature critical pharmaceuticals, and the KTEvolution, a lightweight, manually handleable solution ideal for smaller shipments such as direct-to-patient and last-mile deliveries have helped to meet the latest cold-chain needs.

The company has continued to invest to drive its growth strategy, with UK staff numbers doubling over the last three years. As well as its global hub expansion, Tower also opened its new 26,000 sq ft UK headquarters and centre of excellence in Theale, Reading, including the addition of an Innovation Centre to enhance its design and laboratory testing capabilities in the development of the latest temperature-controlled solutions.

Niall Balfour added; โ€œIt is our vision to become the number-one cold-chain shipping facility of choice worldwide. Winning the prestigious Queenโ€™s Award recognises this journey, acknowledges our customersโ€™ trust, and above all marks the tremendous efforts of all our team at Tower. I would like to thank and congratulate every one of them for their contributionโ€“ this award is a real testament to their support and our continued international growth.โ€

Now in their 56th year, the Queenโ€™s Awards for Enterprise are the most prestigious business awards in the UK, with winning businesses able to use the esteemed Queenโ€™s Awards emblem for the next five years. The Awards recognise British businessesย who excel in specific areas, including international trade, innovation and sustainable development.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Novartis Expands Radioligand Therapy Manufacturing in US

Swiss pharmaceutical company Novartis has started construction of a...

Angelini Pharma Expands US Presence with Catalyst Pharmaceuticals Acquisition

Angelini Pharma has finalized a definitive agreement to acquire...

Are Glutathione Injections in NYC Worth It? A Complete Guide

When whatever you do to your skin makes it...

Fujifilm Advances Drug Discovery with New Cyclic Peptide Screening Platform

FUJIFILM Corporation has developed a new screening methodology aimed...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป